Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 4, 2025 • 4:30 AM ET

Date/Time Source News Release
05/27/2025 08:45 AM EDT GlobeNewswire Vaccinex to Report Promising New Clinical Results of Neoadjuvant Treatment with Pepinemab to Enhance Immunotherapy in Patients with Head and Neck Cancer at ASCO Annual Meeting
04/21/2025 08:45 AM EDT GlobeNewswire Vaccinex to Report Promising New Clinical Data Revealing Pepinemab's Unique Mechanism to Enhance Immunotherapy at Annual Meeting of American Association for Cancer Research (AACR)
03/07/2025 05:15 PM EST GlobeNewswire Vaccinex Plans to Delist its Common Stock from The Nasdaq Stock Market
12/17/2024 09:00 AM EST GlobeNewswire Vaccinex Announces Receipt of Delisting Notification from Nasdaq
11/18/2024 08:30 AM EST GlobeNewswire Vaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate Update
11/07/2024 08:30 AM EST GlobeNewswire Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC
11/05/2024 08:30 AM EST GlobeNewswire Vaccinex Reports Improved Immunity Correlating with Clinical Benefit of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer's Annual Meeting
10/31/2024 10:00 AM EDT GlobeNewswire Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab at Clinical Trials on Alzheimer's Disease (CTAD) Conference in Madrid, Spain
10/24/2024 08:30 AM EDT GlobeNewswire Vaccinex to Report Promising New Efficacy Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab at Clinical Trials on Alzheimer's Disease (CTAD) Conference on October 31, 2024
09/18/2024 08:30 AM EDT GlobeNewswire Vaccinex Announces Exercise of Warrants for $6.2 Million in Gross Proceeds
Page

Additional News

As of June 4, 2025 • 4:30 AM ET

Date/Time Source News Release
03/07/2025 05:21 PM EST SeekingAlpha Vaccinex plans to delist common stock from Nasdaq
01/11/2025 04:31 AM EST US Earnings Reports Expected earnings - Vaccinex Inc.
12/17/2024 09:17 AM EST SeekingAlpha Vaccinex receives delisting notice from Nasdaq, shares down over 49%
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Vaccinex Inc.
11/18/2024 09:17 AM EST SeekingAlpha Vaccinex reports Q3 figures
10/31/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Thu, Oct 31, 2024 as of 4:00 pm ET
10/16/2024 05:01 PM EDT SeekingAlpha Vaccinex files for secondary stock offering
10/08/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Tue, Oct 08, 2024 as of 4:00 pm ET
09/18/2024 08:46 AM EDT SeekingAlpha Vaccinex exercises warrants for proceeds of $6.2M
08/14/2024 10:21 AM EDT SeekingAlpha Vaccinex says Alzheimer's candidate buoyed by additional early-stage data
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.